Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Share-based Compensation: 2019-2024

Historic Share-based Compensation for Molecular Partners Ag (MOLN) over the last 6 years, with Dec 2024 value amounting to $4.7 million.

  • Molecular Partners Ag's Share-based Compensation fell 29.45% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 78.14%. This contributed to the annual value of $4.7 million for FY2024, which is 19.52% down from last year.
  • Molecular Partners Ag's Share-based Compensation amounted to $4.7 million in FY2024, which was down 19.52% from $5.8 million recorded in FY2023.
  • Molecular Partners Ag's 5-year Share-based Compensation high stood at $5.8 million for FY2023, and its period low was $3.2 million during FY2020.
  • For the 3-year period, Molecular Partners Ag's Share-based Compensation averaged around $5.2 million, with its median value being $5.3 million (2022).
  • In the last 5 years, Molecular Partners Ag's Share-based Compensation spiked by 36.60% in 2021 and then dropped by 19.52% in 2024.
  • Molecular Partners Ag's Share-based Compensation (Yearly) stood at $3.2 million in 2020, then skyrocketed by 36.60% to $4.4 million in 2021, then grew by 19.22% to $5.3 million in 2022, then climbed by 9.77% to $5.8 million in 2023, then declined by 19.52% to $4.7 million in 2024.